News

The organization aims to educate viewers of dangers and safety precautions ahead of the eclipses.

LL-BMT1 is a novel, preservative-free, weekly drug-eluting contact lens created by the company’s proprietary 3D printing technology.

Cyclosporine superior to vehicle, improves corneal staining in dry eye disease

Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation

Investigators emphasized that the data does not indicate a causal relationship between eye disorder and systemic diseases.

In the study, published in Nature Biotechnology, researchers used their new system to correct disease-causing mutations in the eyes of two mouse models of genetic blindness, partially restoring their vision.

Their machine-learning multistage system predicts the expected disease progression of patients and their VA with age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

Results show Eylea HD extended dosing regimens were non-inferior to aflibercept 2 mg injection (Eylea) for both the treatment of wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases

The retina specialist shares advice for the clinician-scientists of a digital-centric future

TL-925 is a first in class, topical Bruton’s tyrosine kinase (BTK) inhibitor that prevents mast cell activation and degranulation, and also blocks the cytokine-driven inflammatory response, and restores lacrimal unit homeostasis, offering the potential for disease modification

Jeff Todd, president and CEO of Prevent Blindness, and astrophotographer Jon Carmichael sat down with David Hutton of Ophthalmology Times to talk about how ophthalmologists can help make sure patients are viewing the eclipse safely as well as proper ways to view/photograph the event without damaging your eyes or equipment.

According to the company, the milestone underscores Vivity’s wavefront-shaping technology, which simplifies presbyopia correction for surgeons and patients.

Study concluded that the short-term results of LBN to treat mild-to-modern OAG and OHT was safe and efficacious.

Filomena Ribeiro, MD, PhD, FEBO, discusses the crucial role of mentors – and where to find them

The company has divested its Coherus Ophthalmology subsidiary to Sandoz, Inc. for upfront all-cash consideration of $170 million.

Early detection of the disease is key to optimal patient outcomes

Eyenovia acquired the US commercial rights for the drug last August from Formosa Pharmaceuticals.

Investigators believe that AMD and cancer may have similar risk factors in common.

Day 2 program of the 2024 COPHy conference.

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

The approval marks the first new steroid on the ophthalmic market in more than 15 years.

The 2024 15th annual Controversies in Ophthalmology Congress will convene March 15 and 16 in Athens, Greece.

ChatGPT-4 (OpenAI) had an overall “fair” performance when answering multiple-choice ophthalmic questions unrelated to multifocal imaging.